Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
David Matuskey(Yale University), Richard E. Carson(Yale University), Kyle C. Wilcox(AbbVie (United States)), Robert A. Comley(AbbVie (United States)), Takuya Toyonaga(Yale University), Mark Dias(Itron (United States)), Mika Naganawa(Itron (United States)), Jim Ropchan(Yale University), Brian Pittman(Yale University), Ivonne Suridjan(AbbVie (United States)), Sjoerd J. Finnema(Itron (United States)), Sule Tinaz(Yale University), Yiyun Huang(Guangxi Medical University), Shannan Henry(Itron (United States)), Nabeel Nabulsi(Itron (United States))
Cited by 186
Related Papers
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
Dissociated Pattern of Activity in Visual Cortices and Their Projections During Human Rapid Eye Movement Sleep
|Science|1998|478
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET
|Proceedings of the National Academy of Sciences|2015|349
Synthesis and Preclinical Evaluation of<sup>11</sup>C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
|Journal of Nuclear Medicine|2016|320